Structural Analysis of a Group of Phytoestrogens for the Presence of a 2-D Geometric Descriptor Associated with Non-genotoxic Carcinogens and Some Estrogens

Abstract Analysis of a group of phytoestrogens indicates that the majority of these chemicals are devoid of a 6Å distance descriptor biophore. This 6Å biophore is associated with the carcinogenicity of a set of chemicals in the mouse subset of the Carcinogenic Potency Database assembled by Gold et al. The prevalence of non-DNA-reactive carcinogens and chemicals endowed with estrogenic activity included in the group of chemicals possessing 6Å descriptor suggests that it describes a ligand binding site on an estrogen receptor. Evidence is presented that estrogens with and without the 6Å biophore bind to alternate receptors or to similar receptors but with different affinities. Since the 6Å biophore was identified based upon a carcinogenicity database, it is conceivable that binding to the putative receptor that recognizes this biophore is associated with carcinogenicity. Alternatively, estrogens devoid of this 6Å biophore may be noncarcinogenic, suggesting that carcinogenicity and estrogenicity may be separate phenomena.

[1]  G. Lucier.  Receptor-mediated carcinogenesis. , 1992, IARC scientific publications.

[2]  J. Ashby,et al.  The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures. , 1993, Mutation research.

[3]  M. Shelby.  The genetic toxicity of human carcinogens and its implications. , 1988, Mutation research.

[4]  G. Williams,et al.  The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. , 1993, Carcinogenesis.

[5]  J Ashby,et al.  International Commission for Protection Against Environmental Mutagens and Carcinogens. Two million rodent carcinogens? The role of SAR and QSAR in their detection. , 1994, Mutation research.

[6]  H S Rosenkranz,et al.  Identification of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens and antiestrogens. , 1996, Mutagenesis.

[7]  Malcolm C. Pike,et al.  The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. , 1984 .

[8]  M. Lippman,et al.  Antiestrogenic effects of LY 117018 in MCF-7 cells. , 1983, Endocrinology.

[9]  M. Pike,et al.  A carcinogenic potency database of the standardized results of animal bioassays , 1984, Environmental health perspectives.

[10]  Mechanisms of action of known human carcinogens. , 1992, IARC scientific publications.

[11]  B. Ames,et al.  Second chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986. , 1987, Environmental health perspectives.

[12]  K. Chae,et al.  Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. , 1988, Molecular pharmacology.

[13]  R. Tennant,et al.  Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.

[14]  D. Coradini,et al.  Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells. , 1994, Anticancer research.

[15]  S. Venitt,et al.  Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. , 1992, Carcinogenesis.

[16]  D. Sheehan.  The Case for Expanded Phytoestrogen Research , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  B. Ames,et al.  Chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1982. , 1986, Environmental health perspectives.

[18]  J. Liehr,et al.  Mechanism of genotoxicity of diethylstilbestrol in vivo. , 1989, The Journal of biological chemistry.

[19]  M. Baker,et al.  Endocrine Activity of Plant-Derived Compounds: An Evolutionary Perspective , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[20]  J. Liehr,et al.  Induction of covalent DNA adducts in rodents by tamoxifen. , 1992, Cancer research.

[21]  G. Williams,et al.  Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. , 1993, Cancer research.

[22]  V. Jordan,et al.  Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture. , 1990, Cancer research.

[23]  B. Ames,et al.  Third chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987. , 1987, Environmental health perspectives.

[24]  J. Ashby.  Use of short-term tests in determining the genotoxicity or nongenotoxicity of chemicals. , 1992, IARC scientific publications.

[25]  D G Hoel,et al.  Medical hypothesis: xenoestrogens as preventable causes of breast cancer. , 1993, Environmental health perspectives.

[26]  F. K. Ennever,et al.  The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. , 1987, Mutagenesis.

[27]  H. Rosenkranz,et al.  A study of the structural basis of the carcinogenicity of tamoxifen, toremifene and their metabolites. , 1996, Mutation research.

[28]  L. Black,et al.  Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms. , 1981, Endocrinology.

[29]  G. Klopman.  MULTICASE 1. A Hierarchical Computer Automated Structure Evaluation Program , 1992 .